4 The most influential primary work is a 2008 Gastroenterology study by Dalmasso and colleagues, which showed that KPV is transported into intestinal epithelial cells via the peptide transporter PepT1 and, once inside, reduces pro-inflammatory signaling
Find articles by McFarland, K
In a post hoc analysis of SUSTAIN 6, including 3297 subjects with type 2 diabetes and high CV risk, once-weekly semaglutide reduced the risk of MACE and each MACE component in all subjects included in the trial, regardless of gender, age, or baseline CV risk profile, as compared with placebo [16]
Although Retatrutide is not yet FDA approved, its generating excitement due to remarkable clinical trial results specifically, the TRIUMPH-1 Phase 3 trial, which showcased an average weight loss of up to 28.3% at 80 weeks
It Protects the Brain Beyond peripheral nerve healing, BPC-157 may also protect the brain from damage and support recovery after traumatic brain injury